iSpecimen financials
$1.23+1.65%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $151.9K | $156.0K | $51.8K | $106.6K | $713.1K | $1.1M | $1.5M | $2.7M | $2.9M | $2.3M | $2.6M | $2.8M |
| Gross profit | $68.7K | $71.6K | -$547.1K | -$98.0K | $269.0K | $400.2K | $151.4K | $1.1M | $1.4M | $1.3M | $1.1M | $1.4M |
| Gross margin | 45.2% | 45.9% | −1056.9% | −91.9% | 37.7% | 37.8% | 10.3% | 41.6% | 50.3% | 56.3% | 44.6% | 49.9% |
| Operating income | -$1.4M | -$2.5M | -$2.7M | -$2.8M | -$1.8M | -$1.6M | -$5.8M | -$1.7M | -$2.2M | -$3.0M | -$2.9M | -$2.2M |
| Net income | -$1.4M | -$2.3M | -$5.0M | -$2.8M | -$1.0M | -$1.7M | -$6.0M | -$1.4M | -$2.1M | -$2.9M | -$3.1M | -$2.1M |
| Net margin | −896.9% | −1458.4% | −9662.2% | −2608.7% | −146.9% | −156.8% | −409.8% | −54.1% | −73.6% | −126.7% | −119.3% | −76.0% |
| Diluted EPS | $-0.98 | $-6.66 | $-16.07 | $-19.20 | $-16.78 | $-28.55 | $-213.52 | $-84.00 | $-148.80 | $-254.40 | $-138.91 | $-186.40 |
| EBITDA | -$1.2M | -$2.4M | -$2.3M | -$2.4M | -$1.4M | -$1.2M | -$5.3M | -$1.2M | -$1.6M | -$2.4M | -$2.9M | -$1.7M |
| Operating cash flow | -$689.6K | -$3.4M | -$916.9K | -$2.0M | -$192.2K | -$1.1M | -$3.6M | -$1.1M | -$1.5M | -$2.1M | $345.1K | -$1.6M |
| Free cash flow | -$689.6K | -$3.4M | -$916.9K | -$2.0M | -$192.7K | -$1.1M | -$3.6M | -$1.1M | -$1.5M | -$2.1M | $345.1K | -$1.6M |
| Diluted shares | 1.4M | 0.3M | 0.3M | 0.1M | 0.1M | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.4M | $2.8M | $6.9M | $2.8M | $588.8K | $782.6K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $7.4M | $6.6M | $9.5M | $9.0M | $6.0M | $6.8M |
| Total liabilities | $5.7M | $5.8M | $6.4M | $5.9M | $5.4M | $5.2M |
| Shareholders' equity | $1.7M | $814.0K | $3.1M | $3.1M | $622.0K | $1.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology